Scientists scan brains to see how magic mushrooms work

NCT ID NCT04501653

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study used advanced brain scans to see how psilocybin, the active ingredient in magic mushrooms, affects brain networks. Eleven healthy adults who had used psychedelics before but not recently took part. The goal was to understand the brain changes that might explain psilocybin's rapid antidepressant effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

psilocybin

What this could lead to

If successful, this could help explain how psilocybin produces its rapid antidepressant effects, pointing toward new treatments for depression.

What could go wrong

This is a very small, early-phase study in healthy volunteers, not patients. It is designed to understand brain mechanisms, not to test a treatment. Results may not translate to clinical benefits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSILOCYBIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Washington University

    St Louis, Missouri, 63110, United States